Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1456 AL 1470

Mini-review: Role of the PI3K/Akt pathway and tyrosine phosphatases in Alzheimer's disease susceptibility

Curtis D, Bandyopadhyay S.

Ann Hum Genet. 2021 Jan;85(1):1-6. doi: 10.1111/ahg.12410. Epub 2020 Dec 1.

Spatial Distribution of Tau and β-Amyloid Pathologies and Their Role in Different Alzheimer Disease Phenotypes

Palmqvist S, Eshaghi A.

Neurology. 2021 Feb 2;96(5):191-192. doi: 10.1212/WNL.0000000000011272. Epub 2020 Dec 1.

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease

Zhang F, Zhong RJ, Cheng C, Li S, Le WD.

Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2.

Insight into the roles of CCR5 in learning and memory in normal and disordered states

Necula D, Riviere-Cazaux C, Shen Y, Zhou M.

Brain Behav Immun. 2021 Feb;92:1-9. doi: 10.1016/j.bbi.2020.11.037. Epub 2020 Dec 1.

Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation

Ashrafian H, Zadeh EH, Khan RH.

Int J Biol Macromol. 2021 Jan 15;167:382-394. doi: 10.1016/j.ijbiomac.2020.11.192. Epub 2020 Dec 2.

The association between toxic pesticide environmental exposure and Alzheimer's disease: A scientometric and visualization analysis

Li Y, Fang R, Liu Z, Jiang L, Zhang J, Li H, Liu C, Li F.

Chemosphere. 2021 Jan;263:128238. doi: 10.1016/j.chemosphere.2020.128238. Epub 2020 Sep 4.

Role of reactive oxygen species in the progression of Alzheimer's disease

Bhatt S, Puli L, Patil CR.

Drug Discov Today. 2021 Mar;26(3):794-803. doi: 10.1016/j.drudis.2020.12.004. Epub 2020 Dec 8.

AMPK: A bridge between diabetes mellitus and Alzheimer's disease

Chen M, Huang N, Liu J, Huang J, Shi J, Jin F.

Behav Brain Res. 2021 Feb 26;400:113043. doi: 10.1016/j.bbr.2020.113043. Epub 2020 Dec 8.

Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?

Voronkov M, Cocchiaro B, Stock JB.

Neurochem Int. 2021 Feb;143:104936. doi: 10.1016/j.neuint.2020.104936. Epub 2020 Dec 10.

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Leng F, Edison P.

Nat Rev Neurol. 2021 Mar;17(3):157-172. doi: 10.1038/s41582-020-00435-y. Epub 2020 Dec 14.

Genetic association of BIN1 and GAB2 in Alzheimer's disease: A meta-analysis and systematic review

Hao X, Wang A, Li C, Shao L, Li Y, Yang P.

Geriatr Gerontol Int. 2021 Feb;21(2):185-191. doi: 10.1111/ggi.14109. Epub 2020 Dec 16.

Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis

Daily JW, Kang S, Park S.

Biofactors. 2021 Mar;47(2):218-231. doi: 10.1002/biof.1703. Epub 2020 Dec 21.

Recent Advances in Virtual Screening for Cholinesterase Inhibitors

Miles JA, Ross BP.

ACS Chem Neurosci. 2021 Jan 6;12(1):30-41. doi: 10.1021/acschemneuro.0c00627. Epub 2020 Dec 22.

Glucose metabolism: A link between traumatic brain injury and Alzheimer's disease

Xu XJ, Yang MS, Zhang B, Niu F, Dong JQ, Liu BY.

Chin J Traumatol. 2021 Feb;24(1):5-10. doi: 10.1016/j.cjtee.2020.10.001. Epub 2020 Nov 3.

Deep Brain Stimulation for Alzheimer's Disease: Tackling Circuit Dysfunction

Lam J, Lee J, Liu CY, Lozano AM, Lee DJ.

Neuromodulation. 2021 Feb;24(2):171-186. doi: 10.1111/ner.13305. Epub 2020 Dec 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias